196 related articles for article (PubMed ID: 29574891)
1. Spotlight on small molecules in cardiovascular diseases.
Wang X; Huang Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1111-1113. PubMed ID: 29574891
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.
Zhang SY; Xu MJ; Wang X
Br J Pharmacol; 2018 Apr; 175(8):1230-1240. PubMed ID: 28407200
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of oxidative stress: translational opportunities.
Daiber A; Di Lisa F; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1511-1513. PubMed ID: 28555779
[TBL] [Abstract][Full Text] [Related]
4. Sulfur-containing gaseous signal molecules, ion channels and cardiovascular diseases.
Yu W; Jin H; Tang C; Du J; Zhang Z
Br J Pharmacol; 2018 Apr; 175(8):1114-1125. PubMed ID: 28430359
[TBL] [Abstract][Full Text] [Related]
5. Zebrafish as a tractable model of human cardiovascular disease.
Bowley G; Kugler E; Wilkinson R; Lawrie A; van Eeden F; Chico TJA; Evans PC; Noël ES; Serbanovic-Canic J
Br J Pharmacol; 2022 Mar; 179(5):900-917. PubMed ID: 33788282
[TBL] [Abstract][Full Text] [Related]
6. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
7. Molecular pharmacology of GPCRs.
Langmead CJ; Summers RJ
Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
[TBL] [Abstract][Full Text] [Related]
8. When pharmacology meets the microbiome: new targets for therapeutics?
Hyland NP; Cryan JF
Br J Pharmacol; 2018 Dec; 175(24):4401-4403. PubMed ID: 30478976
[TBL] [Abstract][Full Text] [Related]
9. Trimethylamine N-oxide: breathe new life.
Subramaniam S; Fletcher C
Br J Pharmacol; 2018 Apr; 175(8):1344-1353. PubMed ID: 28745401
[TBL] [Abstract][Full Text] [Related]
10. Inventing new therapies without reinventing the wheel: the power of drug repurposing.
Papapetropoulos A; Szabo C
Br J Pharmacol; 2018 Jan; 175(2):165-167. PubMed ID: 29313889
[TBL] [Abstract][Full Text] [Related]
11. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease.
He J; Bao Q; Yan M; Liang J; Zhu Y; Wang C; Ai D
Br J Pharmacol; 2018 Apr; 175(8):1354-1361. PubMed ID: 28369744
[TBL] [Abstract][Full Text] [Related]
12. Immunity and hypertension: New targets to lighten the pressure.
Vinh A; Drummond GR; Sobey CG
Br J Pharmacol; 2019 Jun; 176(12):1813-1817. PubMed ID: 31127619
[TBL] [Abstract][Full Text] [Related]
13. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
Welsh P; Grassia G; Botha S; Sattar N; Maffia P
Br J Pharmacol; 2017 Nov; 174(22):3898-3913. PubMed ID: 28409825
[TBL] [Abstract][Full Text] [Related]
14. Emerging areas of opioid pharmacology.
Kelly E; Henderson G; Bailey CP
Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in targeting ion channels to treat chronic pain.
Stevens EB; Stephens GJ
Br J Pharmacol; 2018 Jun; 175(12):2133-2137. PubMed ID: 29878335
[TBL] [Abstract][Full Text] [Related]
16. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.
Woodward L; Akoumianakis I; Antoniades C
Br J Pharmacol; 2017 Nov; 174(22):4007-4020. PubMed ID: 27629236
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in research of melatonin and its potential therapeutic applications.
Stanford SC
Br J Pharmacol; 2018 Aug; 175(16):3187-3189. PubMed ID: 30917240
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets.
Wang S; Binder P; Fang Q; Wang Z; Xiao W; Liu W; Wang X
Br J Pharmacol; 2018 Apr; 175(8):1293-1304. PubMed ID: 28548229
[TBL] [Abstract][Full Text] [Related]
19. Cellular metabolism and diseases.
Maiuri MC; Maffia P
Br J Pharmacol; 2021 May; 178(10):2031-2033. PubMed ID: 33932230
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic acetylcholine receptors.
Wonnacott S; Bermudez I; Millar NS; Tzartos SJ
Br J Pharmacol; 2018 Jun; 175(11):1785-1788. PubMed ID: 29878346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
